Old Age Psychiatry Flashcards

1
Q

Macroscopic changes seen in Alzheimer’s Disease

A

Hippocampal atrophy
Cerebral atrophy
Low brain weight
Enlargement of the inferior horn of the lateral ventricle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Microscopic changes seen in Alzheimer’s Disease

A

Senile plaques (extracellular beta amyloid in gray matter)
Neurofibrillary tangles (intracellular tau protein)
Gliosis
Degeneration of the nucleus of Meynert
Hirano bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Progressive supranuclear palsy

A

Neurodegenerative disease that affects cognition, eye movements, and posture.

Vertical gaze dysfunction
Extrapyramidal symptoms
Cognitive dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of fronto-temporal lobar degenerataion

A

Pick’s disease
Progressive non-fluent aphasia/CPA
Sementic dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Features of fronto-temporal dementia

A

Onset before 65
Insidious onset
Relatively preserved memory and visuospatial skills
Personality change and social conduct problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Macroscopic features of fronto-temporal dementias

A

Atrophy of frontal and temporal lobes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Microscopic features of fronto-temporal dementias

A

Pick bodies (tau protein)
Gliosis
Neurofibrillary tangles
Senile plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Features of Pick’s disease

A

Personality change
Impaired social conduct and disinhibition
Hyperorality and increased appetite
Perseveration .

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pathological features of Pick’s disease

A

Focal gyral atrophy with a knife-blade appearances (thin and narrow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Features of chronic progressive aphasia

A

Non fluent speech with short and agrammatic utterances

Comprehension is relatively preserved.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Features of semantic dysphasia

A

Speech is fluent but empty and conveys little meaning.

Unlike in Alzheimer’s memory is better for recent rather than remote events.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dementia due to Parkinson’s

A

Marked problems with executive function.
Verbal and visual memory are affected to a lesser extent.
Other cognitive deficits, such as dysphasia, apraxia, alexia, agraphia, anomia and acalculia, are less pronounced.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Features of cortical dementias

A

Impaired memory
Impaired visuospatial ability
Impaired executive function
Impaired language

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Types of cortical dementia

A

Alzheimer’s disease
Pick’s disease
Creutzfeldt-Jakob disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Features of sub-cortical dementias

A

Generalised slowing of mental processes
Personality change
Mood disorders
Presence of abnormal movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Imaging studies to differentiate Alzheimer’s, vascular dementia and FTD

A

HMPAO SPECT

FDG PET is the second choice.

17
Q

Imaging to confirm dementia with Lewy Bodies

A

(FP-CIT) SPECT (aka DaTscan)

18
Q

Risk factors for paraphrenia

A
Female
Hearing/visual impairment 
Single, no children
CVAs
Social isolation
19
Q

Risk factors for SIADH

A
Being elderly
Being female
Being a smoker
Having medical co-morbidity
Polypharmacy
20
Q

Antipsychotics recommended in delirium

A

haloperidol or olazapine

21
Q

Risk of developing Alzheimer’s disease

A

1% at age 60, doubling every 5 years to 30-50% by age 85

22
Q

Donepezil

A

Reversible acetylcholinesterase inhibitor

23
Q

Galantamine

A

Reversible acetylcholinesterase inhibitor and binds allosterically to the nicotinic acetylcholine receptor

24
Q

Rivastigmine

A

Reversible acetylcholinesterase inhibitor and butyrylcholinesterase inhibitor

25
Q

Memantine

A

NMDA receptor antagonist t

Recommended for patients intolerant of or have a contraindication to AChE inhibitors or for severe Alzheimer’s disease

26
Q

Risk factors for Charles Bonnet syndrome

A
Advanced age
Peripheral visual impairment
Social isolation
Sensory deprivation
Early cognitive impairment
27
Q

Prevalence of dementia

A
  1. 1% in over 65s

1. 3% of the entire UK population.

28
Q

Breakdown of dementia severity

A
  1. 4% have mild dementia
  2. 1% have moderate dementia
  3. 5% have severe dementia
29
Q

Antipsychotics suitable in Parkinson’s

A

Quetiapine and clozapine